Max Robotics — Global Service Robot Directory + US Certification

About

Jacob Buitrago is a researcher at the forefront of precision public health, specializing in population-based genetic screening for inherited disease risk. His work centers on evaluating the feasibility and impact of large-scale genomic screening programs, particularly for actionable conditions like hereditary cancer syndromes and familial hypercholesterolemia. Buitrago’s major contribution is demonstrating that unselected population screening can identify at-risk individuals who would otherwise be missed by traditional family-history-based approaches. His landmark 2023 study, "Population screening shows risk of inherited cancer and familial hypercholesterolemia in Oregon," has already garnered 13 citations, underscoring its influence in shaping screening policy. This work provides critical evidence for integrating genomic screening into routine healthcare, with implications for early intervention and prevention. Buitrago’s research bridges clinical genetics and public health, offering a scalable model for reducing the burden of inherited diseases. His findings are particularly notable for highlighting health disparities and the need for equitable access to genetic testing.